Results 51 to 60 of about 1,058 (107)

Integrase Strand Transfer Inhibitors for Treatment-experienced Young Adults With Perinatal HIV in the US: Immunologic, Virologic, and Anthropometric Outcomes. [PDF]

Clin Infect Dis
Patel K, Jaramillo-Underwood A, Karalius B, Yao TJ, Van Dyke RB, Mirza A, Jao J, Agwu AL, Pediatric HIV/AIDS Cohort Study (PHACS) .   +8 more
europepmc   +1 more source

Fetal Defects in Mice Treated With Integrase Strand Transfer Inhibitors: Comparison of Dolutegravir, Raltegravir, Bictegravir, and Cabotegravir. [PDF]

J Infect Dis
Mohan H, Nguyen J, Yee A, Laurette EY, Sanghvi T, Tejada O, Jao J, Sled JG, Greene NDE, Copp AJ, Serghides L.   +10 more
europepmc   +1 more source

Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. [PDF]

J Acquir Immune Defic Syndr, 2022
Coutinho CM, Warshaw MG, Duarte G, Stek A, Violari A, Hofer CB, Deville JG, Ngocho JS, Pilotto JH, Correa MD, Shapiro DE, Fuller TL, Chakhtoura N, Mirochnick M, João EC.   +14 more
europepmc   +1 more source

Analysis of raltegravir analogs to enhance inhibitory efficiency against HIV integrase. [PDF]

Sci Rep
Sabaghian H, Yoosefian M.
europepmc   +1 more source

Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study. [PDF]

Pharmacogenomics J, 2023
Gurjar R, Dickinson L, Carr D, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, De Castro N, Fätkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Schwimmer C, Raffi F, Boffito M, NEAT001/ANRS143 Study Group.   +16 more
europepmc   +1 more source

Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]

Sci Rep
Nikfarjam Z, Rakhshi R, Zargari F, Aalikhani M, Hasan-Abad AM, Bazi Z.   +5 more
europepmc   +1 more source

Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial treatment for people living with HIV. [PDF]

Clin Trials
Zheng Y, Currier JS, Hughes MD.
europepmc   +1 more source

Potential drug-drug interactions of frequently prescribed medications in long COVID detected by two electronic databases. [PDF]

PLoS One, 2023
Meakleartmongkol T, Tangpanithandee S, Vanavivit N, Jiso A, Pongchaikul P, Kirdlarp S, Khemawoot P, Nathisuwan S.   +7 more
europepmc   +1 more source

Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil? [PDF]

Rev Paul Pediatr
Costa SMD, Aguiar PM.
europepmc   +1 more source

Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy. [PDF]

Int J STD AIDS, 2023
Carvalho S, Sheehan NL, Valois S, Kakkar F, Boucher M, Ferreira E, Boucoiran I.   +6 more
europepmc   +1 more source